The World Health Organization on Wednesday turned the spotlight on the insulin market—and its domination by three Big Pharma giants—in a fresh bid to tackle the rapid rise of diabetes.
The World Health Organization on Wednesday turned the spotlight on the insulin market—and its domination by three Big Pharma giants—in a fresh bid to tackle the rapid rise of diabetes.
